RATING

RECOMMENDATION

Sell

  • ROFR Required
  • Available in Depository:

  • NSDL

  • CDSL

  • Available for Investment:

  • Primary

  • Secondary

RATING

RECOMMENDATION

Sell

Business Type

Near Leader

RATING

RECOMMENDATION

Sell

Business Type

Near Leader

  • Sigachi Laboratories Growth

Get detailed information about the Sigachi Laboratories Pre IPO shares. In this research report, you will get to know about Sigachi Laboratories Limited Key Ratio data. In addition, get the Complete details about the Net Profit Growth, Revenue Growth and Book Value Growth.

Sigachi Laboratories Revenue Growth

Growth in %

  • 123.49%

    1 Year

  • 22.64%

    3 Year

  • 19.05%

    5 Year

The total revenue of the company had increased by 123% from the previous year. Overall, revenue from operations increased by 5x, whilst revenue from other income declined by 63%. The company did not sell any of its fixed assets in FY21, leading to a fall in other income compared with FY20, where the company realised a profit of Rs. 63 lakhs on selling its fixed assets. The company's interest income increased by 11%. Bulk drugs and intermediate-lease rents have increased by 5%. Revenue from fair value gains has improved tremendously from the loss of Rs. 97 Lakhs to gains of Rs. 1.7 Cr. in FY21, contributing the most to the increase in the total revenue of the company as the market conditions recovered in the last two quarters of FY21, the company has realised higher fair value gains and has been able to report higher total revenue in P&L. 

Sigachi Laboratories Net Profit Growth(PAT)

Growth in %

  • 289.79%

    1 Year

  • 35.33%

    3 Year

  • 28.34%

    5 Year

The net profit of the company has improved tremendously, with a 4x increase from FY20. The majority of the net profit is driven by the rise in revenue per unit of expense, which rose from 4.2 in FY20 to 6.9 in FY21, which indicates that the company has improved efficiency in generating revenue while reducing its expenses. Although expenses increased by 37%, this was primarily due to bad bonds at their expense. 

Sigachi Laboratories EPS Growth

Growth in %

  • 288.57%

    1 Year

  • 35.23%

    3 Year

  • 28.38%

    5 Year


  • Sigachi Laboratories Book Value Growth

Growth in %

  • 13.03%

    1 Year

  • 7.30%

    3 Year

  • 13.21%

    4 Year

The company is completely debt-free, which indicates that the company finances its operations only using equity. With higher profits in FY21, the company's total retained earnings increased from Rs. 8 Cr. in FY20 to Rs. 10 Cr. in FY21, as well as a higher comprehensive income of Rs. 4 Cr, which includes profit on sale of equity shares of Rs. 2 Lakhs that flew into other equity part of the company. 

Sigachi Laboratories EBITDA Growth

Growth in %

  • 150.28%

    1 Year

  • 31.12%

    3 Year

  • 22.66%

    5 Year

EBITDA of the company has witnessed 2.5x increase from the previous year. It must be noted that EBITDA of the company has been improving every year with positive . In absolute terms total revenue increased by Rs. 213 lakhs against only Rs. 14 lakhs increase in the total expenses of the company.  

Sigachi Laboratories Operating Profit Growth

Growth in %

  • 168.95%

    1 Year

  • 32.81%

    3 Year

  • 24.13%

    5 Year

The rationale for the increase is because EBITD and EBITDA are both increasing. The company's depreciation increased by only Rs. 1 lakh in FY21 compared to FY20, which was insufficient to improve the company's EBIT growth.

Sigachi Laboratories Asset Growth

Growth in %

  • 33.90%

    1 Year

  • 10.14%

    3 Year

  • 20.67%

    5 Year

The total assets of the company grew by 33% in FY21 from FY20. An increase in the assets has been brought about by an increase in the non-current investments in equity instruments made by the company. Non-current investment increased by Rs. 6 Cr from the previous year as investment in one of the main businesses of the company and markets performed better in FY21 than in FY20, which led to higher investment in FY21. 

Sigachi Laboratories Cash Flow from Operations

Growth in %

  • NA

    1 Year

  • -32.15%

    3 Year

  • NA

    5 Year

Cash flow from operations has improved significantly. The primary reason for the improvement is positive movements in working capital, mostly attributable to the increase in the total receivables of the company.

  • Sigachi Laboratories Solvency Ratios

Sigachi Laboratories D/E Ratio

The company is a debt-free company.

Sigachi Laboratories Current Ratio

The current ratio of the company has improved drastically from FY20, primarily due to an increase in loans, advances, and other current assets of Rs. 17 lakhs, whilst the total current liability decreased by Rs. 1 lakh, leading to a higher multiple. As the company mostly finances its working capital using equity instead of borrowing, which is why the company is debt-free.

Sigachi Laboratories Quick Ratio

The company has no inventories in FY21. 

Sigachi Laboratories Interest Coverage Ratio

The company has no interest expense or related finance cost in FY21.

  • Sigachi Laboratories Operating Efficiency

The operating efficiency of the company has increased sharply because the company had higher EBIT, EBITDA, and PAT than revenue from operations in FY20. Revenue from operations only constitutes 38% of total revenue, leading to higher operating efficiency. In FY21, revenue from operations accounts for 90% of total revenue, increasing the denominator and, as a result, the operating efficiency margin. Although it must be noted that the revenue from operations increased by 5.2x, EBIT grew by 37%, EBIT by 169% and PAT by 3.9x. 

Sigachi Laboratories Operating Profit EBIT Margin(OPM)

Sigachi Laboratories Profit Before Tax Margin (PBT Margin)

Sigachi Laboratories Profit After Tax Margin (PAT Margin)

  • Sigachi Laboratories Profitablity Ratio


Sigachi Laboratories Return on Equity(RoE)

In FY21, ROE grew by 4.5x from FY20, mostly attributable to an increase in net profits of the company, which grew by 3.9x as a result of better tax efficiency and phenomenal growth in revenue from operations. On the other hand, on average, the total equity of the company fell by 13%, leading to significant growth in the ROE of the company.

Sigachi Laboratories Return on Capital Employed(RoCE)

The total capital employed in the company has increased due to the company's plan to increase its efficiency in generating revenue, which has resulted in higher profits and higher returns on the ROCE of the company. 

Sigachi Laboratories Return to Assets (RoA)

ROA has seen a sharp increase by 3.48x from the previous year. The total assets of the company, on average, grew by 11.2% to improve the overall operating efficiency of the company. 

  • Sigachi Laboratories Valuation Ratios

Sigachi Laboratories Earning Yield